<DOC>
	<DOC>NCT01555762</DOC>
	<brief_summary>This multicenter, prospective, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in first-line therapy in elderly patients with metastatic colorectal cancer. Data will be collected from eligible patients for24 months.</brief_summary>
	<brief_title>An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patients, &gt;/= 75 years of age Metastatic colorectal cancer Initiating Avastin firstline therapy in combination with chemotherapy Previous Avastin therapy Patient participating in a clinical study evaluating a cytotoxic anticancer therapy and/or an investigational new drug</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>